• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4627407)   Today's Articles (1073)   Subscriber (49595)
For: McCarthy JE, Dewitt BD, Dumas BA, McCarthy MT. Modeling the relative risk of SARS-CoV-2 infection to inform risk-cost-benefit analyses of activities during the SARS-CoV-2 pandemic. PLoS One 2021;16:e0245381. [PMID: 33507962 PMCID: PMC7842882 DOI: 10.1371/journal.pone.0245381] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2020] [Accepted: 12/29/2020] [Indexed: 12/21/2022]  Open
Number Cited by Other Article(s)
1
Bennett JS, Mahmoud S, Dietrich W, Jones B, Hosni M. Evaluating vacant middle seats and masks as Coronavirus exposure reduction strategies in aircraft cabins using particle tracer experiments and computational fluid dynamics simulations. ENGINEERING REPORTS : OPEN ACCESS 2022;5:e12582. [PMID: 36718395 PMCID: PMC9878082 DOI: 10.1002/eng2.12582] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Revised: 09/29/2022] [Accepted: 10/01/2022] [Indexed: 06/18/2023]
2
Chen P, Zhang D, Liu J, Jian IY. Assessing personal exposure to COVID-19 transmission in public indoor spaces based on fine-grained trajectory data: A simulation study. BUILDING AND ENVIRONMENT 2022;218:109153. [PMID: 35531051 PMCID: PMC9066746 DOI: 10.1016/j.buildenv.2022.109153] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Revised: 04/14/2022] [Accepted: 04/27/2022] [Indexed: 05/09/2023]
3
Matyas D, Wills P, Dewitt B. Imagining Resilient Courts: from COVID-19 to the Future of Canada's Court System. CANADIAN PUBLIC POLICY. ANALYSE DE POLITIQUES 2022;48:186-208. [PMID: 36039066 PMCID: PMC9395162 DOI: 10.3138/cpp.2021-015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
4
Mahdian S, Zarrabi M, Panahi Y, Dabbagh S. Repurposing FDA-approved drugs to fight COVID-19 using in silico methods: Targeting SARS-CoV-2 RdRp enzyme and host cell receptors (ACE2, CD147) through virtual screening and molecular dynamic simulations. INFORMATICS IN MEDICINE UNLOCKED 2021;23:100541. [PMID: 33649734 PMCID: PMC7904474 DOI: 10.1016/j.imu.2021.100541] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Revised: 02/19/2021] [Accepted: 02/20/2021] [Indexed: 02/06/2023]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA